99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization

Summary

This is an open-label single photon emission tomography/computed tomography (SPECT/CT) study to investigate the diagnostic performance and evaluation efficacy of 99mTc-ABH2 in breast cancer patients. A single dose of 370±54 Mega-Becquerel (MBq)99mTc-ABH2 will be injected intravenously. Visual and semiquantitative method will be used to assess the SPECT/CT images.

Timeline

Start

2015-06-24

Primary completion

2017-05-24

Completion

2018-05-18

Drugs

Indications